NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2031210266

Registered date:20/08/2021

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of SR-0379 in Participants with Skin Ulcer

Basic Information

Recruitment status Not Recruiting
Health condition(s) or Problem(s) studiedskin ulcer
Date of first enrollment02/08/2021
Target sample size120
Countries of recruitment
Study typeInterventional
Intervention(s)SR-0379 or placebo spray

Outcome(s)

Primary OutcomeThe days to simple surgical intervention (ncluding suturing, grafts or flaps)
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximum< 85age old
GenderBoth
Include criteriaPatients must have a wound requiring wound bed preparation in advance of planned surgical closure (including suturing, grafts or flaps)
Exclude criteriaPresence of untreated ulcer infection (redness, swelling, pus, foul odor, fever)

Related Information

Contact

Public contact
Name Hideki Tomioka
Address Office for University-Industry Collaboration Bldg. A, 5F No.509, Osaka University 2-1 Yamadaoka, Suita, Osaka Osaka Japan 565-0871
Telephone +81-6-6369-7957
E-mail htomioka@funpep.co.jp
Affiliation FunPep Co., Ltd.
Scientific contact
Name Shigeru Ichioka
Address 38 Morohongo Moroyama-machi, Iruma-gun Saitama Japan 350-0451
Telephone +81-492-76-1299
E-mail ichioka2006@yahoo.co.jp
Affiliation Saitama Medical University Hospital